Physician

Sarabjeet Singh, M.D.

According to 2025 Medicare claims, Sarabjeet Singh, M.D. (NPI: 1295919371) practices cardiology in the Bakersfield-Delano, CA market, with the plurality of this provider's patient population coming from Kern, CA. This provider's primary affiliated billing organization is CENTRIC HEALTH (NPI: 1831248236; TIN: 953511288) and primary practice location at 93309-1985. Singh is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,383 traditional Medicare patients, billed 38,283 HCPCS/CPT codes, and received $1,781,071 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 8,774 prescription claims across 1,399 beneficiaries totaling $1,139,638 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 14 claims. Open Payments data shows 55 records totaling $16,679. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $171,448 to $1,139,638. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $49,388 to $13,785.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,341	8,142	$1,127,039
2016	1,479	12,393	$2,170,350
2017	1,465	12,247	$1,967,452
2018	1,403	21,155	$2,280,585
2019	1,351	20,460	$2,275,248
2020	1,432	36,743	$2,907,223
2021	1,619	29,623	$2,692,255
2022	1,909	23,836	$2,653,633
2023	2,258	32,173	$2,697,428
2024	2,383	38,283	$1,781,071

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	497	3,346	$171,448
2016	641	4,849	$297,549
2017	715	5,659	$383,354
2018	780	5,717	$436,937
2019	923	6,121	$564,045
2020	968	7,021	$584,757
2021	1,005	7,401	$695,135
2022	1,088	7,994	$775,241
2023	1,186	8,000	$1,025,866
2024	1,399	8,774	$1,139,638

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	23	$48,904
2018	N/R	28	$56,664
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	14	$118
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,106	1,148	$142
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	1,088	2,690	$142
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,123	2,179	$85
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	1,785	4,566	$12
93041	Electrocardiogram (ecg) 1 to 3 leads	947	981	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	521	27,353	$522,154
Entresto	Sacubitril/Valsartan	126	5,750	$113,857
Farxiga	Dapagliflozin Propanediol	57	3,800	$67,969
Xarelto	Rivaroxaban	55	3,442	$63,264
Ozempic	Semaglutide	51	1,792	$54,087

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	55	$16,679	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sarabjeet Singh, M.D.?

Tedicare shows public-source Medicare data for Sarabjeet Singh, M.D. (NPI 1295919371), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sarabjeet Singh, M.D. have ACO affiliation data?

Sarabjeet Singh, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Sarabjeet Singh, M.D.?

Sarabjeet Singh, M.D. is linked to CENTRIC HEALTH (billing NPI 1831248236) in the available physician profile data.

Does Sarabjeet Singh, M.D. have Open Payments data?

Sarabjeet Singh, M.D. has 55 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.